Amneal Pharmaceuticals, Inc. is recalling 38,280 bottles of Esterified Estrogens & Methyltestosterone Tablets (0.625 mg/1.25 mg and 1.25 mg/2.5 mg strengths) because testing showed the medication may be subpotent. This means the tablets contain less of the active ingredient than they are supposed to, which could result in patients not receiving their full intended dose of medication. These prescription-only tablets were distributed nationwide in 100-count bottles. Patients should contact their healthcare provider or pharmacist regarding their medication use and return any remaining product to their pharmacy.
The drug is being recalled because it failed 'out of specification' assay results, meaning it is subpotent. If a patient takes subpotent medication, they may not receive the full therapeutic benefit of the hormones, potentially leading to a recurrence or worsening of the symptoms the medication was intended to treat.
Drug recall refund and consultation
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.